Difference between revisions of "Quell relief"
Jump to navigation
Jump to search
(info updated) |
(→Important Dates: row added) |
||
| Line 77: | Line 77: | ||
Melzack and Wall proposed first model for pain relief in 1965 | Melzack and Wall proposed first model for pain relief in 1965 | ||
| + | |||
Developement of TENS (Transcutaneous electrical nerve stimulation) in 1970s | Developement of TENS (Transcutaneous electrical nerve stimulation) in 1970s | ||
Revision as of 23:50, 19 October 2015
| QUELL RELIEF | |
|---|---|
|
|
| Category | Therapeutic wearables |
| Developer | NeuroMetrix |
| Announced | ###"###" contains an extrinsic dash or other characters that are invalid for a date interpretation. |
| Released | Developers: ###"###" contains an extrinsic dash or other characters that are invalid for a date interpretation.
Consumers: 2015 |
| Price | 249 USD |
| Weight | 62 g |
| Dimensions | 98 x 74 x 11 mm |
| Controls | smartphone |
| Standalone[1] | |
| https://www.quellrelief.com/product | |
Contents
Main characteristics
Purpose
Company & People
Important Dates
Melzack and Wall proposed first model for pain relief in 1965
Developement of TENS (Transcutaneous electrical nerve stimulation) in 1970s
Ethical Issues
Health Risks
No health risks are known. Usage is 100% drug free, with clearance by FDA (Food and Drug Administration)
Enhancement/Therapy/Treatment
Quell wearable device has primarily therapeutical function. It was developed on purpose to palliate chronical pain which basically has origin in these four diseases:
Public & Media Impact and Presentation
Public Policy
Related Technologies, Project or Scientific Research
References
- ↑ Shows if the device is a standalone wearable computer or if it needs to be connected to a processing unit to function.
